Bioreactor systems for the production of biopharmaceuticals from animal cells

Biotechnol Appl Biochem. 2006 Jul;45(Pt 1):1-12. doi: 10.1042/BA20050233.

Abstract

The demand for biopharmaceutical products is set to see a significant increase over the next few years. As a consequence, the processes used to produce these products must be able to meet market requirements. The present paper reviews the current technologies available for animal cell culture and highlights the advantages and disadvantages of each method, while also providing details of recent case studies. Processes are described for both suspension and anchorage-dependent cell lines.

Publication types

  • Review

MeSH terms

  • Animals
  • Bioreactors*
  • Biotechnology / instrumentation*
  • Biotechnology / methods
  • CHO Cells / metabolism
  • Cell Culture Techniques / instrumentation*
  • Cell Culture Techniques / methods
  • Cells, Immobilized
  • Cricetinae
  • Cricetulus
  • Dialysis / instrumentation
  • Dialysis / methods
  • Equipment Design / instrumentation
  • Perfusion / methods
  • Recombinant Proteins / biosynthesis*
  • Technology, Pharmaceutical / instrumentation*
  • Technology, Pharmaceutical / methods
  • Vaccines / biosynthesis*

Substances

  • Recombinant Proteins
  • Vaccines